Myriad Genetics is convening surgeons to assess whether MRD testing is ready for wider use in surgery and postoperative cancer care. The panel underscores risin

Myriad Genetics is convening surgeons to assess whether MRD testing is ready for wider use in surgery and postoperative cancer care. The panel underscores rising interest in tools that detect residual disease earlier and guide more tailored treatment.